L
Legend Biotech Corporation (LEGN)
NMS – Real Time Price. Currency in USD
28.69
+0.26 (0.91%)
At close: Jun 26, 2026, 4:00 PM EDT
29.30
+0.61 (2.13%)
After-hours: Jun 26, 2026, 7:07 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
28.69
+0.26 (0.91%)
At close: Jun 26, 2026, 4:00 PM EDT
29.30
+0.61 (2.13%)
After-hours: Jun 26, 2026, 7:07 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $646.4M significantly exceed its total debt $389.3M, ensuring strong financial flexibility
Total current assets $1.1B exceed Total current liabilities $509.1M, highlighting excellent liquidity
Debt-to-equity ratio (0.4) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-8.5x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$111.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.13 | 6.05 | 10 | |
| Quick ratio | 2.05 | 5.63 | 10 | |
| Debt to Equity | 0.40 | 0.30 | 7.0 | |
| Debt to Assets | 0.24 | 1.04 | 7.0 | |
| Interest coverage | -8.53 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 117M | 285M | 628M | 1.03B | 1.14B |
| Gross Profit | 33M | 120M | 369M | 593M | 589M |
| Operating Income | -458M | -442M | -310M | -137M | -132M |
| Net Income | -446M | -518M | -177M | -298M | -251M |
| EBITDA | -439M | -421M | -286M | -108M | -93M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 41.89 | 122.04 | 10 |
| Next quarter | 35.82 | 136.15 | 10 |
| Current year | 39.3 | 104.51 | 10 |
| Next year | 25.87 | 2233.81 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -0.54 | -75.96 | -87.49 | 12.03 | 2.5 |
| Y/Y | 56.66 | 46.11 | 44.44 | 8.08 | 9.0 |
| 3y average | 109.48 | -6.11 | -2.12 | -11.74 | 3.3 |
| 5y average | 77.95 | -16.01 | -3.11 | -4.49 | 3.3 |
| Weighted average score | 4.5 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |